You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 64 No. 7, July 2007 TABLE OF CONTENTS
  Archives
  •  Online Features
  Letters to the Editor
 This Article
 •Full text
 •PDF
 • Reply to article
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citing articles on HighWire
 •Citing articles on Web of Science (2)
 •Contact me when this article is cited
 Related Content
 •Related article
 •Similar articles in this journal
 Topic Collections
 •Journalology/ Peer Review/ Authorship
 •Psychiatry, Other
 •Evidence-Based Medicine
 •Randomized Controlled Trial
 •Alert me on articles by topic
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Del.icio.us Add to Digg Add to Reddit Add to Technorati Add to Twitter What's this?

Publication Bias in Systematic Reviews

Corrado Barbui, MD; Andrea Cipriani, MD

Since this article does not have an abstract, we have provided the first 150 words of the full text and any section headings.

The systematic review carried out by Taylor et al1 suggested that selective serotonin reuptake inhibitors (SSRIs) begin to have observable beneficial effects in depression during the first week of treatment. This result was obtained from the analysis of randomized controlled trials of SSRIs vs placebo that reported outcomes for at least 2 points in the first 4 weeks of treatment. From 107 trial reports, Taylor et al identified 50 randomized controlled trials meeting the inclusion criteria, of which 28 were incorporated in the primary analysis. This pattern of trial selection was a consequence of the fact that not all studies took repeated-outcome measures and not all studies that took repeated-outcome measures presented the results for all points.

We argue that the criteria of including only studies reporting outcomes for at least 2 points in the first 4 weeks of treatment might have systematically selected . . . [Full Text of this Article]


AUTHOR INFORMATION


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter     What's this?

RELATED ARTICLE

Early Onset of Selective Serotonin Reuptake Inhibitor Antidepressant Action: Systematic Review and Meta-analysis
Matthew J. Taylor, Nick Freemantle, John R. Geddes, and Zubin Bhagwagar
Arch Gen Psychiatry. 2006;63(11):1217-1223.
ABSTRACT | FULL TEXT  


THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

The evolution of evidence hierarchies: what can Bradford Hill's 'guidelines for causation' contribute?
Howick et al.
JRSM 2009;102:186-194.
FULL TEXT  





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 2007 American Medical Association. All Rights Reserved.